nitroglycerin has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.33) | 18.7374 |
| 1990's | 29 (60.42) | 18.2507 |
| 2000's | 13 (27.08) | 29.6817 |
| 2010's | 1 (2.08) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Akima, M; Imagawa, J; Nabata, H; Taira, N | 1 |
| Chapat, S; Janis, RA; Johnson, DE; Watts, JA | 1 |
| Bucknall, CA; Moncada, S; Palmer, RM; Smith, RE | 1 |
| Mayhan, WG | 2 |
| Satoh, K; Taira, N; Yamada, H; Yoneyama, F | 1 |
| Satoh, K; Taira, N; Yamada, H | 1 |
| Benjamin, N; Dutton, JA; Ritter, JM | 1 |
| Angus, JA; Keily, SG; McPherson, GA | 1 |
| Bult, H; Fret, HR; Herman, AG; Jordaens, FH | 1 |
| Barrow, SE; Benjamin, N; Doktor, HS; Mant, TG; Ritter, JM; Schey, S; Stewart-Long, P | 1 |
| Aoki, N; Lefer, AM; Mulloy, D | 1 |
| Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Henry, PJ; Horowitz, JD; Louis, WJ | 1 |
| Pearl, RG; Prielipp, RC; Rosenthal, MH | 1 |
| Hyman, AL; Kadowitz, PJ; Lippton, HL; Nandiwada, PA | 1 |
| de la Lande, IS; Horowitz, JD; Zhang, CL | 1 |
| Chang, JK; Heaton, J; Hyman, A; Lin, B; Lippton, H; Steinberg, S | 1 |
| Gillis, CN; Rimar, S | 1 |
| Bell, DR; Koritnik, DR; Koshy, A; Rensberger, HJ | 1 |
| Kampf, G; Ritter, JM | 1 |
| Hosoki, K; Kikuta, C; Yamamoto, T | 1 |
| Acuff, TE; He, GW; Mack, MJ; Ryan, WH; Yang, CQ | 1 |
| Chen, L; Katopodis, J; Mehta, JL; Nichols, WW; Nicolini, FA; Robbins, WC; Saldeen, TG; Yang, B | 1 |
| De la Lande, IS; Horowitz, JD; Stafford, I; Zhang, CL | 1 |
| Angerio, AD; Kot, PA; Ramwell, PW; Santoian, EC; Thomas, G | 1 |
| Buxton, BF; Johnston, CI; Liu, JJ | 1 |
| Ahmad, A; Floten, S; Furnary, A; Gately, H; He, GW; Starr, A; Swanson, J; Wood, J; Yang, CO | 1 |
| De la Lande, IS; Horowitz, JD; Stafford, I | 1 |
| Grimminger, F; Mayer, K; Otterbein, J; Schütte, H; Seeger, W; Spriestersbach, R; Walmrath, D | 1 |
| Huraux, C; Levy, JH; Makita, T; Nordlander, M; Szlam, F | 1 |
| He, GW | 1 |
| He, GW; Yang, CQ | 1 |
| Benjamin, N; Blake, D; Millar, T; O'Byrne, S; Shirodaria, C; Stevens, C | 1 |
| Brockman, D; Eis, A; Kossenjans, W; Myatt, L; Sahay, R | 1 |
| Gong, F; Hoshina, M; Ichihashi, K; Kikuchi, Y; Momoi, MY; Sato, Y; Shiraishi, H | 1 |
| Kurumatani, H; Matsushita, T; Tamura, M | 1 |
| Gong, F; Momoi, MY; Shiraishi, H | 1 |
| Arias, ME; Levy, JH; Sato, N; Szlam, F; Tanaka, KA; Tsuda, A | 1 |
| Hobbs, AJ; MacAllister, RJ; Madhani, M; Scotland, RS | 1 |
| Delagrange, P; Hammad, H; O'Rourke, ST; Scalbert, E; Vanhoutte, PM | 1 |
| Bény, JL | 1 |
| Arshad, M; Floyd, BC; Gupte, SA; Marks, B; Sarabu, MR; Vijay, V; Wolin, MS | 1 |
| Dou, D; Gao, Y; Qi, H; Qin, X; Raj, JU; Zheng, X | 1 |
| Grant, S; Miller, MR; Wadsworth, RM | 1 |
| George, S; Gupte, SA; Hintze, TH; Kaminski, PM; Kouznestova, L; Mathew, R; Olson, SC; Wolin, MS | 1 |
| Hughes, DA; Kroon, PA; Liu, XH; Needs, PW; Rayment, S; Suri, S; Taylor, MA; Tribolo, S; Wilson, VG | 1 |
| He, GW; Hou, HT; Wang, J; Wang, ZQ; Yang, Q | 1 |
1 trial(s) available for nitroglycerin and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in man.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Biphenyl Compounds; Bleeding Time; Blood Pressure; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Interactions; Heart Rate; Heptanoic Acids; Humans; Male; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane | 1990 |
47 other study(ies) available for nitroglycerin and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiocardiography; Animals; Benzopyrans; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Cromakalim; Dogs; Female; Glyburide; Male; Niacinamide; Nicorandil; Nitroglycerin; Parasympatholytics; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Vasodilator Agents | 1992 |
Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Coronary Disease; Endothelins; Heart; In Vitro Techniques; Myocardial Reperfusion; Myocardium; Nisoldipine; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Vasoconstriction | 1992 |
Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Ornithine; Perfusion; Prostaglandin Endoperoxides, Synthetic; Rabbits; Vasoconstriction; Venous Pressure | 1992 |
Responses of cerebral arterioles during chronic ethanol exposure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Alcoholism; Animals; Arterioles; Blood Pressure; Cerebrovascular Circulation; Histamine; Male; Nitroglycerin; Pia Mater; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Reference Values; Vasodilation | 1992 |
Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Coronary Vessels; Dogs; Female; Guanylate Cyclase; In Vitro Techniques; Male; Methylene Blue; Muscle Relaxation; Nitro Compounds; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Purinones; Vasodilator Agents | 1991 |
Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Benzopyrans; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; Glyburide; Guanidines; Male; Methylene Blue; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nitroglycerin; Pinacidil; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Vasodilator Agents | 1991 |
Human vascular smooth muscle cells inhibit platelet aggregation when incubated with glyceryl trinitrate: evidence for generation of nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Cells, Cultured; Hemoglobins; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; Nitrites; Nitroglycerin; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic | 1991 |
Responses of the basilar artery to products released by platelets during chronic hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Basilar Artery; Blood Platelets; Hypertension; Male; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Vasodilation | 1991 |
Spasmolytic effect of cromakalim in dog coronary artery in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzopyrans; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; In Vitro Techniques; Muscle Relaxation; Nitroglycerin; Nitroprusside; Parasympatholytics; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Serotonin; Vasodilator Agents | 1991 |
Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Animals; Aorta, Thoracic; Dipyridamole; Drug Synergism; Epoprostenol; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Phenylephrine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Vasodilation | 1991 |
Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Male; Myocardial Reperfusion; Nitric Oxide; Nitroglycerin; Polydeoxyribonucleotides; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Superoxide Dismutase; Superoxides | 1990 |
Methylene blue selectively inhibits pulmonary vasodilator responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Blood Pressure; Bradykinin; Cats; Cyclic GMP; Epinephrine; Female; Isoproterenol; Male; Methylene Blue; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Reference Values; Vasodilation | 1989 |
Determinants of in vitro nitroglycerin tolerance induction and reversal: influence of dose regimen, nitrate-free period, and sulfhydryl supplementation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcysteine; Animals; Cattle; Drug Tolerance; In Vitro Techniques; Muscle Relaxation; Nitrates; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Sulfhydryl Compounds | 1989 |
Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Disease Models, Animal; Hydralazine; Hypertension, Pulmonary; Nitroglycerin; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Sheep; Vasodilator Agents | 1988 |
Influence of cyclooxygenase blockade on responses to isoproterenol, bradykinin and nitroglycerin in the feline pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Bradykinin; Cats; Cyclooxygenase Inhibitors; Female; Indomethacin; Isoproterenol; Male; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Vascular Resistance | 1984 |
Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cattle; Coronary Vessels; Drug Interactions; Drug Tolerance; Endothelins; Endothelium, Vascular; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
Pulmonary vasodilation to adrenomedullin: a novel peptide in humans.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adrenomedullin; Animals; Bronchodilator Agents; Calcitonin Gene-Related Peptide; Guanidines; Humans; In Vitro Techniques; Injections, Intra-Arterial; Isoproterenol; Male; Muscle, Smooth, Vascular; Nitroglycerin; Peptide Fragments; Peptides; Pinacidil; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents; Vasodilation | 1995 |
Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Administration, Inhalation; Animals; Blood Pressure; Free Radicals; In Vitro Techniques; Lung; Nitric Oxide; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rabbits; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents; Vasodilation | 1995 |
Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Arginine; Calcimycin; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Female; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Nitroglycerin; Orchiectomy; Prostaglandin Endoperoxides, Synthetic; Reference Values; Sex Characteristics; Swine; Tamoxifen; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1995 |
Time-dependent inhibition by glyceryl trinitrate of platelet aggregation caused by U46619 (a thromboxane/endoperoxide receptor agonist).
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Drug Interactions; Humans; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Thromboxane A2; Vasoconstrictor Agents | 1994 |
U-46619-induced ischaemic electrocardiographic changes in rats: preventive effects of prostacyclin and nitroglycerin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Analysis of Variance; Animals; Blood Platelets; Blood Pressure; Coronary Vessels; Disease Models, Animal; Electrocardiography; Epoprostenol; Heart Rate; Injections, Intra-Arterial; Injections, Intravenous; Male; Myocardial Ischemia; Nitroglycerin; Platelet Aggregation; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Greater contractility of internal mammary artery bifurcation: possible cause of low patency rates.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Endothelins; Graft Occlusion, Vascular; Humans; In Vitro Techniques; Internal Mammary-Coronary Artery Anastomosis; Mammary Arteries; Nitroglycerin; Norepinephrine; Potassium; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Cardiac Pacing, Artificial; Constriction; Coronary Circulation; Coronary Vessels; Dogs; Female; Heart; Heart Rate; Leukocytes; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Nitric Oxide; Nitroglycerin; Oxygen; Peroxidase; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1994 |
S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Captopril; Cattle; Coronary Vessels; Dose-Response Relationship, Drug; Drug Tolerance; In Vitro Techniques; Nitroglycerin; Nitroso Compounds; Penicillamine; Prostaglandin Endoperoxides, Synthetic; S-Nitroso-N-Acetylpenicillamine; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1994 |
Vasodilator effects of hydroxylamine in the isolated rodent lung.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hydroxylamine; Hydroxylamines; In Vitro Techniques; Male; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents | 1993 |
Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Drug Synergism; Humans; In Vitro Techniques; Mammary Arteries; Muscle Relaxation; Nisoldipine; Nitroglycerin; Potassium; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Milrinone; Nitroglycerin; Phosphodiesterase Inhibitors; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Heterogeneity of glyceryl trinitrate response in isolated bovine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Cattle; Coronary Vessels; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Penicillamine; Prostaglandin Endoperoxides, Synthetic; S-Nitroso-N-Acetylpenicillamine; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Efficiency of aerosolized nitric oxide donor drugs to achieve sustained pulmonary vasodilation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Aerosols; Animals; Female; Lung; Male; Molsidomine; Nitric Oxide; Nitroglycerin; Nitroprusside; Prodrugs; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sydnones; Thromboxane A2; Vasodilation | 1997 |
The vasodilator effects of clevidipine on human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Calcium Channel Blockers; Endothelium, Vascular; Humans; In Vitro Techniques; Mammary Arteries; Muscle Contraction; Muscle Relaxation; Nitroglycerin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Verapamil plus nitroglycerin solution maximally preserves endothelial function of the radial artery: comparison with papaverine solution.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Calcimycin; Coronary Artery Bypass; Drug Combinations; Endothelium, Vascular; Humans; In Vitro Techniques; Ionophores; Nitroglycerin; Papaverine; Radial Artery; Safety; Specimen Handling; Tissue Preservation; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Verapamil | 1998 |
Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Drug Interactions; Endothelin-1; Humans; In Vitro Techniques; Nitroglycerin; Nitroprusside; Potassium; Radial Artery; Vasodilation; Vasodilator Agents; Verapamil | 1999 |
Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Allopurinol; Animals; Binding, Competitive; Cattle; Dose-Response Relationship, Drug; Drug Interactions; Humans; In Vitro Techniques; Nitric Oxide; Nitroglycerin; Oxyhemoglobins; Platelet Aggregation; Superoxide Dismutase; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Xanthine Oxidase | 2000 |
Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Antihypertensive Agents; Diabetes Mellitus, Type 1; Epoprostenol; Female; Fetus; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitroglycerin; Oxidative Stress; Placenta; Pre-Eclampsia; Pregnancy; Reactive Oxygen Species; Tyrosine; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Inhalation of nebulized nitroglycerin in dogs with experimental pulmonary hypertension induced by U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Dogs; Hemodynamics; Hypertension, Pulmonary; Nebulizers and Vaporizers; Nitroglycerin; Vascular Resistance; Vasodilator Agents | 2000 |
Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Antihypertensive Agents; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Humans; Hypertension, Pulmonary; Male; Nifedipine; Nitroglycerin; Oxygen; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
The effects of inhalation of nebulized nitroglycerin on dogs with experimental pulmonary hypertension induced by U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Dogs; Hypertension, Pulmonary; Nebulizers and Vaporizers; Nitroglycerin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Dopamine; Dose-Response Relationship, Drug; Female; Fenoldopam; Humans; Hydralazine; In Vitro Techniques; Muscle Contraction; Nicardipine; Nitroglycerin; Potassium Chloride; Pre-Eclampsia; Pregnancy; Receptors, Adrenergic, alpha; Thromboxane A2; Umbilical Arteries; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Guanylate Cyclase; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; Mice, Knockout; Muscle Relaxation; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Phenylephrine; Polysaccharides; Quinoxalines; Receptors, Atrial Natriuretic Factor; Signal Transduction; Spermine | 2003 |
Melatonin inhibits nitrate tolerance in isolated coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isometric Contraction; Isoproterenol; Melatonin; Muscle, Smooth, Vascular; Naphthalenes; Nitrates; Nitroglycerin; Receptors, Melatonin; Swine; Tachyphylaxis; Time Factors; Tryptamines; Vasoconstriction; Vasodilation; Vasodilator Agents | 2003 |
Characterization of purine receptors in mouse thoracic aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Aorta, Thoracic; Biological Factors; Calcimycin; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Phenylephrine; Receptors, Purinergic P2; Uridine Triphosphate | 2004 |
Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adrenergic alpha-Agonists; Calcium Channel Blockers; Colforsin; Coronary Artery Bypass; Epoprostenol; Guanylate Cyclase; Humans; Internal Mammary-Coronary Artery Anastomosis; Isometric Contraction; Mammary Arteries; Nifedipine; Nitric Oxide; Nitroglycerin; Norepinephrine; Organ Specificity; Phenylephrine; Potassium Chloride; Radial Artery; Receptors, Cytoplasmic and Nuclear; Receptors, Thromboxane; Soluble Guanylyl Cyclase; Thromboxane A2; Vascular Patency; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blotting, Western; Coronary Vessels; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Selective arterial dilatation by glyceryl trinitrate is not associated with nitric oxide formation in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbachol; Dose-Response Relationship, Drug; In Vitro Techniques; Isoproterenol; Male; Mesenteric Artery, Superior; Myography; Nitric Oxide; Nitroglycerin; Oxygen; Phenylephrine; Rats; Rats, Sprague-Dawley; Renal Veins; Time Factors; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |
Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Cattle; Coronary Vessels; Membrane Glycoproteins; Mice; Muscle Contraction; Muscle, Smooth, Vascular; NADPH Oxidase 2; NADPH Oxidases; Nitroglycerin; Peroxides; Phorbol 12,13-Dibutyrate; Protein Kinase C; Reactive Oxygen Species; Receptors, Thromboxane; src-Family Kinases; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Arteries; Bradykinin; Coronary Vessels; Cyclic GMP; Drug Tolerance; Morpholines; Nitroglycerin; Nitroprusside; Pyrazoles; Pyrimidines; Quercetin; Sus scrofa; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2010 |
Antispastic Effect of Fasudil and Cocktail of Fasudil and Nitroglycerin in Internal Thoracic Artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Humans; Mammary Arteries; Nitroglycerin; Potassium Chloride; Vasodilator Agents | 2023 |